Rivaroxaban vs warfarin for mechanical heart valves
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares a newer blood thinner (rivaroxaban) to the standard one (warfarin) for people with mechanical heart valves who have had clots or bleeding while on warfarin, or who cannot easily monitor their INR levels. It aims to see if rivaroxaban is safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a mechanical heart valve and are an adult 18 or older.
- You have had a blood clot or bleeding problem while taking warfarin, or you have limited access to INR testing.
- You are willing and able to give informed consent.
- You have not had a hemorrhagic or ischemic stroke in the last 3 months.
- You do not have severe kidney disease (creatinine clearance below 30 mL/min).
- You do not have a condition that raises your risk of bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.
This study tests a blood thinner (rivaroxaban) versus usual care to see if it can prevent strokes in older adults with extra heartbeats (a sign of possible heart rhythm problems) and high stroke risk. If you qualify, the treatment might reduce your chances of having a stroke.
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
This trial studies whether a standard blood thinner, vitamin K antagonist, is safe and effective for people with mechanical heart valves caused by rheumatic heart disease. It may help prevent blood clots and valve-related complications.
This study compares two commonly used blood thinners (apixaban and rivaroxaban) to see which works better for people with non-valvular atrial fibrillation, a type of irregular heartbeat. The goal is to find the safest and most effective option for preventing strokes.
Hear when a new Valvular Heart Disease Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.